OAC
DRUG

OMERS Administration Corp’s Bright Minds Biosciences DRUG Stock Holding History

OMERS Administration Corp’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,000
Closed -$505K – 930
2025
Q1 		$505K Buy
+14,000
New +$512K ﹤0.01% 734

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OMERS Administration Corp's DRUG Position: Q2 2025 in Review

OMERS Administration Corp sold out of Bright Minds Biosciences (DRUG) in Q2 2025, closing a stake of 14,000 shares — an estimated $505K sold.

OMERS Administration Corp first reported a position in DRUG in Q1 2025 and held it in 1 quarter. The position peaked at $505K in Q1 2025. 47 funds tracked by Wall St. Rank hold DRUG as of Q2 2025.

  • OMERS Administration Corp reported no remaining Bright Minds Biosciences position as of Q2 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 14,000 Bright Minds Biosciences shares in Q2 2025, an estimated $505K.
  • OMERS Administration Corp first reported a position in Bright Minds Biosciences in Q1 2025 and held it in 1 quarter.
  • OMERS Administration Corp's Bright Minds Biosciences position peaked at $505K in Q1 2025.
  • 47 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2025.

Based on OMERS Administration Corp's 13F filing for Q2 2025, filed 13 Aug 2025.